EP1626697A4 - Compositions pharmaceutiques pour administration par voie orale, comprenant du carbonate de lithium - Google Patents

Compositions pharmaceutiques pour administration par voie orale, comprenant du carbonate de lithium

Info

Publication number
EP1626697A4
EP1626697A4 EP04753033A EP04753033A EP1626697A4 EP 1626697 A4 EP1626697 A4 EP 1626697A4 EP 04753033 A EP04753033 A EP 04753033A EP 04753033 A EP04753033 A EP 04753033A EP 1626697 A4 EP1626697 A4 EP 1626697A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical compositions
oral administration
lithium carbonate
lithium
carbonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04753033A
Other languages
German (de)
English (en)
Other versions
EP1626697A2 (fr
Inventor
Christopher Charles Abney
Brandeon Scott Hampton
James Russell Norton
Daniel Joseph Schave
George Ronald Tomaich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of EP1626697A2 publication Critical patent/EP1626697A2/fr
Publication of EP1626697A4 publication Critical patent/EP1626697A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
EP04753033A 2003-05-29 2004-05-20 Compositions pharmaceutiques pour administration par voie orale, comprenant du carbonate de lithium Withdrawn EP1626697A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47409603P 2003-05-29 2003-05-29
US10/619,766 US20040241252A1 (en) 2003-05-29 2003-07-15 Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
PCT/US2004/016135 WO2004105691A2 (fr) 2003-05-29 2004-05-20 Compositions pharmaceutiques pour administration par voie orale, comprenant du carbonate de lithium

Publications (2)

Publication Number Publication Date
EP1626697A2 EP1626697A2 (fr) 2006-02-22
EP1626697A4 true EP1626697A4 (fr) 2010-06-09

Family

ID=33457546

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04753033A Withdrawn EP1626697A4 (fr) 2003-05-29 2004-05-20 Compositions pharmaceutiques pour administration par voie orale, comprenant du carbonate de lithium

Country Status (4)

Country Link
US (1) US20040241252A1 (fr)
EP (1) EP1626697A4 (fr)
JP (1) JP2007500225A (fr)
WO (1) WO2004105691A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010220A1 (it) * 2001-02-05 2002-08-05 Valpharma Sa Formulazioni multiparticolate per somministrazione orale di sali di litio idonee per una somministrazione al giorno
EP1737473A4 (fr) * 2004-04-19 2009-08-26 Noven Therapeutics Llc Combinaisons de lithium et utilisations associees
US20080085318A1 (en) * 2005-07-16 2008-04-10 Cherukuri S R Coated compositions and methods for preparing same
US20070219272A1 (en) * 2006-02-06 2007-09-20 Johan Stjernschantz Novel method and compositions for treatment of tinnitus
RU2537035C2 (ru) 2010-03-31 2014-12-27 Колгейт-Палмолив Компани Композиция для ухода за полостью рта
CN113521024A (zh) * 2017-04-17 2021-10-22 上海葆隆生物科技有限公司 一种碳酸锂缓释片

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471100A1 (fr) * 1990-08-14 1992-02-19 Ali Müderrisoglu Comprimés de carbonate de lithium à libération prolongée et leur préparation
WO2002011740A2 (fr) * 2000-08-10 2002-02-14 Unihart Corporation Compositions pharmaceutiques renfermant du carbonate de lithium

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036713A (en) * 1976-03-04 1977-07-19 Foote Mineral Company Process for the production of high purity lithium hydroxide
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
IT1245891B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
EP0546593B1 (fr) * 1991-10-30 1997-09-03 Glaxo Group Limited Compositions multicouches contenant d'antagonistes de l'histamine ou de la sérotonine
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
CA2305535A1 (fr) * 1997-10-03 1999-04-15 Gopadi M. Venkatesh Formes galeniques solides a liberation controlee au carbonate de lithium
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
US6500459B1 (en) * 1999-07-21 2002-12-31 Harinderpal Chhabra Controlled onset and sustained release dosage forms and the preparation thereof
WO2002024169A1 (fr) * 2000-09-20 2002-03-28 Skyepharma Canada Inc. Procede de sechage par atomisation et compositions de fenofibrate
BRPI0506829A (pt) * 2004-01-13 2007-05-29 Univ Duke composições de anticonvulsivo e droga antipsicótica e métodos para sua utilização para afetar perda de peso

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471100A1 (fr) * 1990-08-14 1992-02-19 Ali Müderrisoglu Comprimés de carbonate de lithium à libération prolongée et leur préparation
WO2002011740A2 (fr) * 2000-08-10 2002-02-14 Unihart Corporation Compositions pharmaceutiques renfermant du carbonate de lithium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARANCIBIA A ET AL: "Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations", INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY ANDTOXICOLOGY, DUSTRI- VERLAG FEISTLE, DEISENHOFEN/MUENCHEN, DE, vol. 24, no. 5, 1 May 1986 (1986-05-01), pages 240 - 245, XP009132950, ISSN: 0174-4879 *

Also Published As

Publication number Publication date
US20040241252A1 (en) 2004-12-02
WO2004105691A2 (fr) 2004-12-09
EP1626697A2 (fr) 2006-02-22
JP2007500225A (ja) 2007-01-11
WO2004105691A3 (fr) 2006-01-05

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
IL176519A0 (en) Directly compressible pharmaceutical composition for the oral administration of cci-779
EP1757273A4 (fr) Preparation pour administration orale
HK1107768A1 (en) Solid drug for oral use
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
AU2003246978A1 (en) Pharmaceutical compositions comprising cyclosporin for oral administration
ZA200605080B (en) Pharmaceutical compositions
GB0300531D0 (en) Pharmaceutical compositions
EP1648411A4 (fr) Compositions pharmaceutiques
HK1093896A1 (en) Medicinal composition
GB0229258D0 (en) Medicinal compositions
EP1626697A4 (fr) Compositions pharmaceutiques pour administration par voie orale, comprenant du carbonate de lithium
EP1655029A4 (fr) Compositions medicinales
GB0213481D0 (en) Pharmaceutical compositions
EP1600445A4 (fr) Preparation curative
HK1098059A1 (en) Composition comprising itraconazole for oral administration
EP1480649A4 (fr) Compositions pharmaceutiques stables
TWI340649B (en) A pharmaceutical composition containing alkaline medicament
AU2003201886A1 (en) Medicinal compositions for improving oral absorption
PL373776A1 (en) Oral pharmaceutical compound
ZA200603126B (en) Pharmaceutical compositions for therapeutic use
GB0305579D0 (en) Pharmaceutical compositions
EP1508332A4 (fr) Composition medicinale
PL370907A1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20051118

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/24 20060101ALI20060616BHEP

Ipc: A61P 25/18 20060101ALI20060616BHEP

Ipc: A61K 47/00 20060101ALI20060616BHEP

Ipc: A61K 9/20 20060101ALI20060616BHEP

Ipc: A61K 33/00 20060101AFI20060616BHEP

RAX Requested extension states of the european patent have changed

Extension state: LV

Payment date: 20051118

Extension state: LT

Payment date: 20051118

Extension state: HR

Payment date: 20051118

A4 Supplementary search report drawn up and despatched

Effective date: 20100511

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100821